Home / Guides / Veterinary Business Valuation

Veterinary Business Valuation: 2026 Multiples by Practice Model

Buy-side M&A across 76+ active capital partners · Veterinary M&A: GP, specialty, ER, urgent care, mobile · Updated June 5, 2026

Veterinary business valuation produces the widest multiple range of any consumer healthcare category, from 5x EBITDA for single-doctor general practices to 22x EBITDA for AVMA-accredited specialty and emergency hospitals. The reason is structural: a veterinary practice is really four different businesses (single-doctor general practice, multi-doctor GP, specialty and emergency, and urgent-care or mobile), and the consolidator buyer pool values them very differently. AAHA accreditation, doctor compensation as a percentage of production, and real estate ownership are the three signals that move multiples most after EBITDA size. This guide maps the practice models, explains which signals consolidator buyers actually test in diligence, walks through a worked example for a Texas multi-doctor GP, and identifies the pre-sale changes that produce the most multiple lift. If you are a veterinary practice owner evaluating your options, this is the valuation framework you need before any consolidator conversation. A deeper read on private equity in veterinary 2026 covers the same ground from the sponsor side with the supporting deal data.

Methodology and data sources

This valuation guide follows CT Acquisitions’ 5-tier source hierarchy: T1 press releases for major sponsor and platform transactions (NVA, AVG, MVP, PetVet, VEG), T2 SEC filings of public-company comparables, T3 sponsor portfolio pages, T4 industry-research publishers (VetPartners 2024 industry survey, Brakke Consulting, AVMA Economic State of the Profession, Cherry Bekaert veterinary practice benchmarks, AAHA Compensation and Benefits Survey, Peak Business Valuation), and T5 M&A trade press (Veterinary Practice News, Today’s Veterinary Business, AAHA Trends). Every numeric multiple range on this page is reconciled against at least two T4 sources plus CT’s internal VERIFIED_MULTIPLES benchmark.

Tier framing: Headline multiple ranges reflect transactions with named consolidator buyers in 2024-2026. Premium specialty and ER multiples (15x to 22x) reflect AVMA-board-certified specialists, 24/7 emergency coverage, and proven referral pipelines; they are not universally available and require specialty-quality clinical characteristics.

Verification window: All multiples and tier figures verified May 25, 2026 against the named T4 publishers’ most-recent reports plus CT’s active-engagement data. Multiples by tier are sensitive to credit-market conditions, doctor bench depth, AAHA status, real-estate structure, and geography; the cited ranges are starting points for transaction-specific valuation, not deal-specific quotes.

Veterinary-specific industry-data sources: VetPartners 2024 Veterinary Valuation Benchmarks Survey, Brakke Consulting Veterinary Industry Report, AVMA US Pet Ownership and Demographics Sourcebook, AAHA Compensation and Benefits Survey, Cherry Bekaert Veterinary Practice Benchmarking Report. Mars Petcare, JAB (NVA), and the sponsor-backed consolidators do not disclose practice-level transaction multiples; CT’s VERIFIED_MULTIPLES lock is built from confidential transaction observations and reconciled against the listed T4 publishers.

The short answer: typical veterinary valuations in 2026

Specialty and ER tier ranges reflect transactions involving Mars Petcare (BluePearl), MedVet, Ethos Veterinary Health, and VEG. These multiples apply only to practices with AVMA-board-certified specialists, established referral networks, and the operational characteristics consolidators underwrite at platform-grade pricing. For a sponsor-side view of the deal flow producing these multiples, see Private Equity in Veterinary 2026.

The four veterinary practice models

Before any valuation analysis, identify which of these models describes your practice. The same EBITDA dollar produces a very different number depending on which model you operate.

1. Single-doctor general practice

One owner DVM, sometimes with a part-time relief associate, typically 1 to 4 exam rooms, 8 to 15 support staff. Annual revenue $700K to $2.5M, EBITDA margin 15 to 22 percent. This is the highest-volume segment by practice count, accounting for roughly 40 percent of independent practices per the AVMA Economic State of the Profession 2024-2025. Valuations 5x to 8x EBITDA, with AAHA accreditation and real-estate ownership being the two key levers within the band. Consolidator interest is real but bidding is less competitive than for multi-doctor platforms because integration economics are weaker.

2. Multi-doctor general practice

2 to 6 DVMs, typically including the owner DVM plus 1 to 5 associate DVMs on ProSal. Annual revenue $2.5M to $12M, EBITDA margin 17 to 24 percent. Platform-grade general practice tier. This is the segment most aggressively pursued by NVA, AVG, MVP, VetCor, PetVet, and Pathway. Valuations 10x to 15x EBITDA for AAHA-accredited operators with associate bench depth (owner produces less than 50 percent of total revenue). A 3-doctor AAHA practice in a target metro typically attracts 4 to 8 bidders.

3. Specialty and emergency hospitals

AVMA-board-certified specialists (surgery, internal medicine, oncology, radiology, dermatology, neurology, criticalist) and/or 24/7 emergency coverage with overnight technicians and licensed veterinarians. Annual revenue $5M to $40M+, EBITDA margin 18 to 28 percent. Valuations 15x to 22x EBITDA. Buyer pool narrows but is intensely competitive: BluePearl (Mars), MedVet, Ethos Veterinary Health (Sound Point Capital since 2022 recapitalization), VEG / Veterinary Emergency Group (backed by Vista Equity Partners), and a handful of regional specialty platforms. AVMA Council on Education accreditation for the residency program (if applicable) is heavily valued.

4. Urgent care and mobile

Urgent care clinics (no overnight, no surgery, no board-certified specialists) bridge GP and ER. Annual revenue $1.5M to $5M, EBITDA margin 15 to 22 percent. Valuations 8x to 12x EBITDA, with VEG-style urgent-care models trending higher as the segment matures. Mobile veterinary practices (typically a single rig with a DVM and a vet tech) trade at 3x to 5x SDE; the buyer pool is largely independent practitioners and small regional consolidators rather than national platforms.

Most multi-doctor practices combine two or three of these models (for example, a GP with after-hours urgent care). The valuation approach depends on the mix. A practice that is 80 percent GP plus 20 percent urgent care is valued primarily as a GP. Flip the mix and the valuation calculus flips with it.

Where the real value lives: specialty and emergency

Specialty and emergency hospitals are the only sub-category where veterinary practices routinely command 18x to 22x EBITDA multiples. Understanding why matters:

• Referral revenue is inherently sticky. Once a specialty hospital is the referral destination for the GPs in a metro, the network effect compounds. Buyers price this defensibility.
• Board-certified specialists are scarce. AVMA recognizes 22 veterinary specialty colleges, and the supply of new diplomates per year is constrained by residency capacity. A practice with 3+ board-certified DVMs on staff has a real moat.
• 24/7 ER coverage is operationally expensive but pricing-power-rich. Emergency case ARPU (average revenue per visit) is typically 3 to 5 times GP, and consolidators can layer additional revenue (in-house imaging, specialty consults, internal referrals) once the operational base is acquired.
• Capex barriers protect incumbents. A new specialty hospital build is $5M to $15M (CT scanner $300K to $800K, MRI $1M to $2.5M, surgical suite, ICU). De novo competition is rare in established markets.
• The buyer pool is intense and well-capitalized. BluePearl operates over 100 hospitals, MedVet over 35, Ethos over 145, VEG over 80 emergency-only hospitals. Auctions for proven specialty platforms produce real multiple expansion.

If you are primarily a GP owner with one or two associate specialists embedded, the highest-return 2 to 4 year investment is recruiting a third board-certified specialist and formalizing the referral pipeline. It is slow and capital-intensive, but produces durable multiple expansion.

The AAHA accreditation premium

The American Animal Hospital Association accredits roughly 12 to 15 percent of US veterinary practices per AAHA published figures. AAHA accreditation is voluntary, requires meeting over 900 standards across anesthesia, surgery, pain management, dentistry, diagnostic imaging, emergency care, and medical records, and is reassessed every 3 years.

For consolidator buyers, AAHA accreditation signals three things: (1) standardized clinical protocols already in place, reducing post-close integration cost; (2) better medical records and case documentation, reducing diligence friction; (3) higher fee schedules typically supportable in the local market because AAHA status is consumer-visible.

The premium is real and consistent. Across CT Acquisitions’ transaction observations and reconciled against VetPartners survey data, AAHA-accredited GP practices trade at a 1 to 2 turn EBITDA premium over comparable non-accredited practices in the same market. On a $1.5M EBITDA multi-doctor practice, that is $1.5M to $3M of additional consideration. The cost to achieve AAHA accreditation is typically $25K to $75K plus 12 to 24 months of operational preparation; the ROI on pre-sale AAHA pursuit is one of the highest available to a veterinary owner.

Fear Free certification (a separate behavior-focused certification) is increasingly common and adds incremental valuation lift but is not a substitute for AAHA. Most consolidator buyers treat AAHA as a primary signal and Fear Free as a desirable bonus.

DVM compensation, ProSal, and the EBITDA rebuild

The single most common diligence finding that compresses veterinary valuations is owner DVM compensation set below market ProSal. The owner produces $900K of personal revenue, takes a $180K salary plus profit, and the practice shows a $1.2M EBITDA. The buyer rebuilds the EBITDA at market ProSal (typically 20 to 23 percent of personal production) and discovers $200K to $300K of pre-tax compensation must be added back to the owner’s W-2 cost. The EBITDA drops to $900K to $1M, and the offered consideration drops with it.

Market ProSal rates by role (per AAHA Compensation and Benefits Survey 2024 and VetPartners survey data):

• Associate DVM, GP: 20 to 22 percent of personal production, or salary equivalent of $110K to $160K base depending on geography. Top metros (San Francisco, NYC, Boston) trend higher.
• Associate DVM, specialty or ER: 22 to 25 percent of production, or $180K to $300K+ base plus production bonus for board-certified specialists.
• Medical Director: Base $150K to $200K plus 22 to 25 percent of personal production plus 2 to 5 percent of practice EBITDA bonus.
• Owner DVM: Should be normalized to associate DVM ProSal of 20 to 22 percent of personal production for valuation purposes.

The rebuild process every consolidator runs in diligence:

1. Pull production reports by DVM for trailing 24 months from the practice management system (Cornerstone, ezyVet, AVImark, Impromed).
2. Calculate each DVM’s personal production (revenue attributable to that DVM’s exams, procedures, and recommendations).
3. Apply market ProSal rate (20 to 22 percent GP, 22 to 25 percent specialty) to each DVM’s production.
4. Compare to actual W-2 cost (base salary plus production bonus plus benefits plus payroll taxes).
5. Adjust EBITDA for the gap. Under-compensated owner DVMs get a downward EBITDA adjustment; over-compensated associates get an upward EBITDA adjustment.

This rebuild typically moves EBITDA by 10 to 25 percent in one direction or the other. Owners who normalize their own compensation 18 to 24 months before sale and run the practice on the rebuilt EBITDA for a clean trailing-12-month period eliminate this diligence friction entirely. See how to sell a service business for the full pre-sale preparation playbook.

How consolidator buyers actually calculate the number

1. Pull and normalize the EBITDA. Rebuild DVM compensation at market ProSal, adjust owner real-estate rent to fair market, remove personal expenses, normalize one-time costs (equipment writedowns, owner discretionary spending).
2. Decompose the revenue mix. Split by service category (wellness exams, surgery, dentistry, diagnostics, pharmacy, food, boarding, grooming) and by DVM. Pharmacy and food retail are typically discounted to lower multiples because online competition (Chewy, Amazon) is structural pressure.
3. Analyze the doctor bench. Owner DVM production as a percent of total practice revenue. Less than 30 percent is platform-grade. 30 to 50 percent is acceptable. Over 60 percent triggers owner-dependence discount.
4. Model forward cash flow. Project forward revenue with explicit attrition assumptions for owner DVM (typically 100 percent transitions out within 36 months) and any associate DVMs at risk of departure.
5. Compare to consolidator comparables. Adjust for AAHA status, geography, real-estate structure, specialty mix, and recent consolidator transactions in the same metro.
6. Apply the concluding multiple and propose the deal structure (typically 70 to 85 percent cash at close plus equity rollover or earnout).

The seven factors that move veterinary multiples

1. Practice model and EBITDA scale

The single largest valuation driver. A multi-doctor AAHA GP at $1.5M EBITDA trades at 12x to 14x. A single-doctor non-AAHA GP at $400K EBITDA trades at 5x to 6.5x. This is a 6 to 8 turn differential before any other factor is considered.

2. AAHA accreditation status

1 to 2 turn premium as detailed above. The premium is most pronounced for multi-doctor GP and specialty practices and less material for single-doctor GP under $500K EBITDA.

3. Doctor bench depth (owner production share)

• Premium bench: Owner DVM produces less than 30 percent of total revenue, 2+ associate DVMs in stable long-term roles, formal medical director structure.
• Good bench: Owner produces 30 to 45 percent, 1 to 2 associates, informal medical director.
• Average bench: Owner produces 45 to 60 percent, 1 associate, no formal medical director.
• Weak bench: Owner produces over 60 percent, owner is sole DVM or relies on relief vets, no associate bench.

4. Real estate ownership and structure

Owned real estate is generally valued at 6.5 to 8.5 percent cap rate outside the operating-practice multiple. A practice doing $1.5M EBITDA in a building it owns valued at $250K of fair-market rent: the operating practice is valued on a market-rent-adjusted EBITDA, and the real estate is separately appraised at cap-rate value. Sale-leaseback structures with 10-year triple-net leases are the standard exit for owner-occupants. See the real-estate section below for full mechanics.

5. Practice management software and clinical data

• Premium: ezyVet (cloud-native, strong reporting), Cornerstone (Idexx, ubiquitous in larger practices), or Impromed with 2+ years of clean data. Strong inventory management, dispenseable item tracking, and DVM production reporting.
• Standard: AVImark, ImproMed (older versions), or DVMAX.
• Discount: Paper records or DOS-era software. Post-close PIMS migration costs $50K to $150K and disrupts operations.

6. Pharmacy and retail revenue mix

In-house pharmacy and food retail used to be high-margin add-ons. Online competition (Chewy PetMeds, Amazon, Vetsource home delivery) has compressed pharmacy margin to 25 to 35 percent gross from 50 percent a decade ago. Consolidator buyers typically value pharmacy revenue at a discount to medical services revenue. Practices with high pharmacy mix (over 25 percent of revenue) face modest multiple compression versus services-heavy practices.

7. Geography and DVM recruiting

Top metros with deep DVM labor pools (Dallas, Austin, Atlanta, Charlotte, Denver, Phoenix, Nashville, Tampa) command premium consolidator interest because the buyer can reliably recruit replacement associates. Practices in rural markets or DVM-scarce regions face structural risk: if the owner exits and the consolidator cannot recruit a replacement, the practice cannot operate.

Real estate vs lease impact on valuation

Roughly 50 to 65 percent of independent GP veterinary practices operate from owner-occupied real estate. The treatment of that real estate at close is one of the most consequential structural decisions in a veterinary transaction.

The three standard structures:

• Sale-leaseback at fair-market rent. Owner sells the building separately to the consolidator (or to a third-party net-lease REIT) at cap-rate value, and the practice operates under a new long-term lease (typically 10 to 15 years triple-net with 2 to 3 percent annual escalators). This is the most common structure for $1M+ EBITDA transactions. The operating EBITDA is rebuilt at fair-market rent before the multiple is applied.
• Owner retains the building, leases to consolidator. Owner keeps the real estate as a long-term yield asset and the practice leases at fair-market rent. The operating EBITDA is rebuilt at the new lease rate, and the multiple is applied. Owner monetizes the building separately on their own timeline. This is increasingly common for owners under 60 who want yield income post-transaction.
• Long-term lease already in place with third-party landlord. No real-estate transaction. The consolidator inspects lease terms (remaining term, escalators, assignment clauses, renewal options) and adjusts the multiple slightly downward if terms are unfavorable.

The owner-occupied math: A practice doing $1.5M reported EBITDA where the owner pays themselves $0 rent (operates in their own building with no rent expense booked) is not actually a $1.5M EBITDA practice. Apply fair-market rent of $180K per year, and the operating EBITDA is $1.32M. The multiple is applied to $1.32M; the building is valued separately at cap rate. Owners who do not normalize rent before sale routinely have $1M to $3M of value mis-allocated in their head.

Capex differences by practice model

Veterinary practices vary widely in capital intensity. Buyers diligence the trailing 3 years of capex and the forward 3-year replacement schedule.

• Single-doctor GP: Maintenance capex typically $25K to $60K per year (dental units, anesthesia machines, autoclaves, basic imaging refresh). Major replacement cycles every 7 to 10 years.
• Multi-doctor GP: $75K to $200K per year (digital dental radiography, in-house lab analyzers, ultrasound, surgical equipment). Replacement schedules tighter because utilization is higher.
• Specialty hospital: $250K to $800K per year (CT scanner replacement every 8 to 10 years at $300K to $800K, MRI every 10 to 12 years at $1M to $2.5M, surgical robots, endoscopy, fluoroscopy). Capex is a meaningful drag on free cash flow.
• Emergency hospital: $200K to $500K per year (defibrillators, ventilators, ICU monitoring, surgical equipment, in-house lab). Higher equipment utilization means faster replacement.
• Mobile veterinary: $30K to $80K per year (vehicle replacement every 5 to 7 years at $80K to $200K for a fully equipped mobile rig).

A 3-year forward capex schedule is standard diligence in any specialty or ER transaction. Be prepared to show it with vendor quotes for major replacements.

The named consolidator buyer pool in 2026

The veterinary consolidator landscape is the deepest in any consumer healthcare category. The named platforms below are actively acquiring in 2026:

• Mars Petcare , Largest by revenue. Owns VCA Animal Hospitals (over 1,000 GP hospitals), Banfield Pet Hospital (over 950 hospitals, primarily PetSmart-embedded), BluePearl (over 100 specialty and ER hospitals), and AniCura (European platform, also operating in select US markets). Combined US practice count exceeds 2,000.
• JAB Holdings / National Veterinary Associates (NVA) , Over 1,400 hospitals globally including the former Compassion-First specialty platform (acquired 2020). JAB also owns Pretty Litter and Galenmed in the broader pet care ecosystem.
• PetVet Care Centers , KKR and Ontario Teachers’ Pension Plan ownership. Over 450 hospitals across the US.
• American Veterinary Group (AVG) , Oak Hill Capital portfolio. Approximately 360 clinics, primarily Southeast and Mid-Atlantic.
• Mission Veterinary Partners (MVP) , Shore Capital Partners exited to Morgan Stanley Capital Partners in late 2023. Over 190 hospitals.
• VetCor , Oak Hill Capital and Harvest Partners ownership. Approximately 280 practices.
• Pathway Vet Alliance , TSG Consumer Partners portfolio. Approximately 300+ clinics.
• VEG / Veterinary Emergency Group , Backed by Vista Equity Partners. Over 80 emergency-only hospitals nationally; the dominant pure-play ER consolidator.
• Ethos Veterinary Health , Sound Point Capital recapitalization 2022. Over 145 hospitals, specialty and ER focus.
• MedVet , Independent specialty and ER platform, over 35 hospitals.
• Heart + Paw , Independence Capital portfolio. Approximately 50 clinics.
• Encore Vet Group , Aquiline Capital Partners portfolio.
• Suveto , Apax Partners portfolio. Approximately 40 clinics.
• CityVet , Imperial Capital and Highview Capital portfolio.
• People+Pets Health , Imperial Capital portfolio, smaller regional roll-up.
• Lakefield Veterinary Group , American Securities portfolio.
• Mountain Vet Group , Goldman Sachs portfolio.
• Encompass Vet Group , Pamlico Capital portfolio.
• Innovetive Petcare , Tyree & D’Angelo, Quad-C, Tier4 partnership.

For a $1M+ EBITDA multi-doctor GP practice in a top metro, a properly run process typically attracts 5 to 10 of the above to engage. For a $3M+ EBITDA specialty platform, 6 to 8 of the specialty-focused consolidators (BluePearl, MedVet, Ethos, VEG, NVA, Mars, AVG, MVP) will compete directly. This competitive depth is what produces real multiple expansion versus single-bidder negotiations.

Worked example: $1.2M EBITDA 3-doc GP practice in Texas

Practice profile:

• $6.8M revenue, $1.2M reported EBITDA (17.6 percent margin)
• 3 DVMs: 1 owner DVM, 2 associate DVMs on ProSal
• AAHA accredited since 2019, Fear Free certified since 2022
• Mix: 62 percent medical services (exams, surgery, dentistry, diagnostics), 18 percent in-house pharmacy, 12 percent food retail, 6 percent boarding, 2 percent grooming
• Owner DVM personal production: $1.45M (21 percent of revenue)
• Each associate DVM production: $1.15M and $0.95M (16.9 and 14 percent of revenue)
• Owner produces 21 percent of revenue (premium bench)
• Medical director role formalized 2023, owner DVM serves part-time
• ezyVet PIMS since 2021, clean data
• Suburban Dallas metro, owned real-estate (4,200 sqft purpose-built hospital on 0.85 acres)
• Practice pays owner $0 rent (operates in owner-occupied building, fair-market rent approximately $185K per year)
• Owner W-2 comp $215K, personal expenses on books $35K, one-time costs (HVAC replacement, parking lot resurface) $45K
• 2 surgery suites, in-house digital radiology, in-house lab (Idexx), dental radiography, ultrasound, no CT

EBITDA normalization:

• Reported EBITDA: $1.2M
• Owner ProSal rebuild: owner production $1.45M at 21 percent ProSal = $304K market comp. Owner W-2 is $215K, so add back $0 (owner is slightly under-compensated, but only by $89K which is within normal variance and consolidator does not typically downward-adjust within 15 percent variance band).
• Owner compensation excess pulled to balance: $0 net adjustment
• Fair-market rent normalization: subtract $185K from EBITDA (practice currently pays $0 rent in owner-occupied building)
• Personal expenses add-back: +$35K
• One-time costs add-back: +$45K
• Normalized operating EBITDA (post fair-market rent): $1.095M

Multiple assessment:

• Starting benchmark for AAHA-accredited 3-doctor GP in target Dallas metro: 12.5x
• +0.5x for owner producing less than 30 percent of revenue (premium bench)
• +0.3x for ezyVet with clean reporting data
• +0.2x for Fear Free certification
• −0.3x for pharmacy and food retail mix at 30 percent (above the 25 percent threshold consolidators discount)
• −0.2x for absence of CT or advanced imaging (limits specialty referral revenue)
• Concluding operating multiple: 13.0x

Indicative valuation (operating practice): $1.095M x 13.0x = $14.2M

Real estate (valued separately): $185K fair-market rent at 7.0 percent cap rate = $2.64M

Total transaction value (operating practice + real estate sale-leaseback): $14.2M + $2.64M = $16.84M

24-month improvement path:

• Recruit a 4th associate DVM and shift owner to 12 to 14 percent of revenue production (production transitions to associates): EBITDA grows organically to $1.25M, multiple lifts to 13.5x. Outcome: $16.9M operating practice + $2.64M RE = $19.5M.
• Reduce pharmacy and food mix to under 25 percent by adding wellness plan subscriptions (recurring revenue) and bundled services: multiple to 13.7x. Outcome: $17.1M + $2.64M = $19.7M.
• Recruit a 1.5 FTE board-certified internal medicine specialist on a part-time consulting model to start building referral revenue: multiple to 14.0x. Outcome: $17.5M + $2.64M = $20.1M.
• Combined plausible outcome over 24 months: $20.5M to $21.5M total transaction value.

$3.7M to $4.7M delta over 24 months of preparation. For most veterinary owners, this is the single highest-ROI use of pre-sale capital and operational attention.

How to increase your veterinary practice value before selling

Highest ROI

• Achieve AAHA accreditation. If not already accredited, the 12 to 24 month investment of $25K to $75K plus operational rigor typically produces 1 to 2 turns of multiple expansion. Single highest-ROI pre-sale action for non-accredited multi-doc GP practices.
• Reduce owner DVM production share. Recruit associate DVMs and transition cases. Target owner producing less than 30 percent of total revenue. Run the rebuilt P&L for 12+ months before going to market.
• Normalize owner compensation to market ProSal. Eliminate the diligence rebuild that consolidators will perform anyway. Run the clean P&L for a trailing-12-month period.
• Migrate to ezyVet or modern Cornerstone. Clean PIMS data with 2+ years of history is non-negotiable for premium pricing. Migration takes 4 to 9 months; complete it 18+ months before sale.
• Formalize the medical director structure. Document case escalation protocols, peer review, formulary management. Buyers value documented clinical governance.

Medium ROI

• Pursue Fear Free certification across the clinical team.
• Add wellness plan subscription revenue (e.g., Premier Pet Plans, VetSource, in-house wellness club) to convert one-time clients into recurring revenue.
• Recruit a part-time or full-time board-certified specialist if your scale and case mix supports it (internal medicine and dermatology have the lowest specialist-acquisition cost).
• Document and inventory equipment with photo records, serial numbers, and remaining useful life.
• Renew or extend the building lease (if leased) for 10+ years with reasonable escalators before going to market.

Lower ROI

• Website redesign.
• Social media or marketing automation.
• Adding boarding or grooming if the core medical practice has unfilled DVM capacity (fix the DVM capacity issue first).

Common mistakes that destroy veterinary valuations

• Owner DVM compensation set below market ProSal. Consolidators will rebuild; the EBITDA shown in your tax return is not the EBITDA the offered consideration will be based on.
• Operating in owner-occupied real estate at $0 rent. Fair-market rent normalization is universal; owners who do not plan for it have an unpleasant first conversation.
• No AAHA pursuit despite multi-doctor scale. Leaving 1 to 2 turns on the table is the most common multi-million-dollar veterinary mistake.
• Going to a single consolidator without competition. Even the most reputable national platforms negotiate harder when they know they are the only conversation. A properly run process with 5+ engaged bidders typically produces 0.5 to 1.5 turns of multiple expansion over a single-bidder negotiation.
• Owner-dependent client relationships not transitioned. If 40 percent of the active patient base specifically requests the owner DVM and the owner intends to retire at close, post-close revenue attrition is a real risk that buyers will price in via earnout or holdback.
• Aggressive pharmacy and food retail emphasis without recognizing online pressure. Buyers discount this revenue and may forecast continued margin compression.
• Practice management software older than 5 years with poor data hygiene. Buyers cannot underwrite premium pricing on a practice they cannot diligence.
• Outdated equipment not flagged in the capex schedule. A deferred CT or MRI replacement is a direct purchase-price deduction.

Getting a valuation for your veterinary practice

CT Acquisitions offers confidential veterinary business valuation for practice owners. We specialize in multi-doctor GP and specialty practices in the $500K to $5M EBITDA range, with direct mandate relationships across the named consolidator pool (Mars Petcare divisions, NVA, AVG, MVP, VetCor, PetVet, Pathway, BluePearl, MedVet, VEG, Ethos, and regional roll-ups). CT Acquisitions is paid by the buyer at close; veterinary owners pay nothing. Book a 15-minute conversation or use our free valuation tool for a first-cut indicative range.

About the Author

Christoph Totter is the founder of CT Acquisitions, a buy-side partner headquartered in Sheridan, Wyoming. We work directly with 100+ buyers, search funders, family offices, lower middle-market PE, and strategic consolidators, including direct mandates with the largest veterinary consolidators that other intermediaries cannot access. The buyers pay us when a deal closes, not the seller. No retainer, no exclusivity, no contract until close. Connect on LinkedIn · Get in touch

Sources and references

Every multiple range, practice-tier figure, and industry-data citation on this page is sourced to a published industry-research publisher or to CT Acquisitions’ internal benchmark dataset.

• VetPartners , 2024 Veterinary Valuation Benchmarks Survey and AAHA Compensation and Benefits Survey reconciliation
• AVMA Economic State of the Profession , Practice ownership, DVM workforce data, revenue per FTE benchmarks (2024-2025)
• AAHA (American Animal Hospital Association) , Accreditation standards, Compensation and Benefits Survey, practice management benchmarks
• Brakke Consulting , Veterinary Industry Report, consolidator transaction commentary
• Cherry Bekaert Veterinary Practice Benchmarking Report , Revenue mix, EBITDA margin benchmarks by practice size
• Peak Business Valuation: Veterinary Practice Valuation
• Today’s Veterinary Business , Consolidator transaction reporting
• CT Acquisitions VERIFIED_MULTIPLES dataset , Locked-in vertical-specific multiple ranges reconciled against the above sources; updated quarterly
• CT Acquisitions PE Roll-Up Tracker series , Cross-references include veterinary PE, dermatology DSO, dental DSO, and adjacent healthcare consolidator categories

Last verified: May 25, 2026. Next refresh: quarterly (target 2026-08-25).

Disclaimer: This guide is general veterinary business valuation framework intelligence, not legal, tax, accounting, or transaction advice. CT Acquisitions is a buy-side advisor.

Frequently asked questions about veterinary business valuation

What is the average veterinary practice multiple in 2026?

Across all transactions, simple average is 9x to 11x EBITDA. Multi-doctor AAHA GP practices trade at 11x to 15x. Single-doctor GP practices trade at 5x to 8x. Specialty and ER hospitals trade at 15x to 22x. Practice model and AAHA status matter more than EBITDA size within the same tier.

Is a single-doctor practice worth selling to a consolidator?

Yes, but expect different economics. Single-doctor GP practices trade at 5x to 8x EBITDA versus 10x to 15x for multi-doctor GP. The named consolidators (NVA, AVG, MVP, VetCor) acquire single-doctor practices but typically at the lower end of their range. Many single-doctor sellers transition to associate DVM roles within the consolidator post-close.

How much does AAHA accreditation actually add to my veterinary practice valuation?

A lot. AAHA-accredited GP practices typically command a 1 to 2 turn EBITDA premium over comparable non-accredited practices. On a $1.5M EBITDA multi-doctor practice, that is $1.5M to $3M of additional consideration. The cost to achieve accreditation is typically $25K to $75K plus 12 to 24 months of preparation, making it one of the highest-ROI pre-sale investments available.

Do I add back owner DVM salary to EBITDA?

Partially. Owner DVM compensation should be normalized to market ProSal (typically 20 to 22 percent of personal production for GP, 22 to 25 percent for specialty). If the owner is paid below market ProSal, the difference is an EBITDA deduction the consolidator will apply in diligence. If paid above market, the excess is an EBITDA add-back. The rebuild typically moves EBITDA by 10 to 25 percent.

Should I own my building or sell it before going to market?

Most owners do best with a sale-leaseback at close. The operating practice is valued at a multiple of fair-market-rent-adjusted EBITDA, and the building is sold separately at cap-rate value (typically 6.5 to 8.5 percent). Combined consideration is usually higher than either selling the building separately on a different timeline or trying to roll the real-estate value into the practice multiple.

How do consolidator buyers evaluate my doctor bench?

They calculate owner DVM personal production as a percent of total practice revenue. Less than 30 percent is platform-grade and commands premium pricing. 30 to 50 percent is acceptable. Over 60 percent triggers owner-dependence discount and typically structured deal terms (earnout, holdback, extended owner retention period).

Is Fear Free certification a valuation issue?

Fear Free is an increasingly common behavior-focused certification (separate from AAHA’s medical-operational accreditation). Most consolidator buyers value it as a desirable bonus that signals modern clinical culture, but it does not substitute for AAHA accreditation. Adds incremental valuation lift, not full turns.

How long does it take to sell a veterinary practice?

90 to 150 days from LOI to close for a well-prepared multi-doctor practice. Preparation runway is 6 to 24 months depending on starting position (AAHA pursuit, PIMS migration, ProSal normalization, real-estate structure). Specialty and ER transactions can extend timelines because diligence is more intensive.

How much will I pay in taxes on the sale?

Federal long-term capital gains plus 3.8 percent NIIT on the goodwill portion. State taxes vary materially (Texas, Florida, Nevada have no state income tax; California is approximately 13.3 percent top rate). Personal goodwill allocation can shift up to 50 percent of consideration into capital-gains-only treatment. Structural planning can reduce effective rate meaningfully; consult your tax counsel 18 to 24 months before sale.

What is the best time of year to sell a veterinary practice?

Practice revenue is relatively non-seasonal (modest summer uptick for boarding and travel-related care). LOI timing typically aligns with the consolidator’s fiscal year planning cycle (often late spring or early fall for the major platforms). Close timing aligns with whatever produces the cleanest trailing-12-month financials for diligence.

Do I need a banker for a veterinary practice sale?

For practices above $2M EBITDA, a properly run process with 5+ engaged consolidator bidders typically produces 0.5 to 1.5 turns of multiple expansion over a single-bidder negotiation. Whether you use a buy-side advisor (paid by the buyer at close, $0 to seller) or a sell-side banker (paid by the seller, typically 1 to 3 percent of transaction value) depends on the structure. CT Acquisitions operates on the buy-side model: no fee to the veterinary owner.

What is the typical deal structure for a veterinary consolidator transaction?

Typically 70 to 85 percent cash at close, with the balance in equity rollover (into the consolidator’s holdco), earnout (tied to forward EBITDA performance), or seller note. Multi-doctor practices over $1M EBITDA can usually negotiate higher cash percentages (85 to 95 percent). Specialty and ER transactions often include larger equity rollover components because the consolidator wants to retain key specialists post-close.

Veterinary valuation vs dental DSO valuation: how they compare

Veterinary practices and dental practices share many structural similarities (single-doctor and multi-doctor models, production-based compensation, owner-occupied real estate, deep consolidator buyer pools) and are frequently compared by sellers evaluating exit options. The valuation differences are meaningful and worth understanding.

• Multi-doctor veterinary GP trades at 11x to 15x AAHA accredited; multi-provider dental practices trade at 7x to 10x DSO-adjusted EBITDA. Veterinary commands a premium because the consolidator buyer pool is deeper (20+ active platforms versus 10 to 12 for dental) and the average deal velocity is higher.
• Specialty veterinary (surgery, internal medicine, oncology) trades at 15x to 18x; dental specialty (orthodontics, oral surgery, endodontics) trades at 9x to 13x. Veterinary specialty has fewer board-certified specialists nationally because residency capacity through AVMA-recognized programs is constrained, which creates a scarcity premium.
• Emergency veterinary trades at 16x to 20x; there is no direct dental equivalent. 24/7 ER veterinary is a structurally protected segment with VEG, BluePearl, MedVet, and Ethos competing intensely for proven hospitals.
• AAHA accreditation (veterinary) and CODA (dental) both carry premium signals, but AAHA is the stronger differentiator because AAHA is voluntary and held by only 12 to 15 percent of practices, while CODA accreditation is a baseline requirement for dental education programs (not for clinical practices).
• Real estate treatment is identical: both verticals use sale-leaseback at fair-market rent with operating EBITDA rebuilt, and the building valued separately at cap rate (6.5 to 8.5 percent).

For a side-by-side comparison of dental DSO multiples and consolidator structures, see dental practice business valuation and the dental DSO PE roll-up tracker.

State-by-state tax considerations for veterinary owners

Federal tax treatment of a veterinary practice sale is consistent nationally: long-term capital gains rate plus 3.8 percent NIIT on the goodwill portion. State income tax variation produces material differences in after-tax proceeds for owners who can plan domicile or transaction timing.

• No state income tax states (Texas, Florida, Tennessee, Nevada, Washington, Wyoming, South Dakota, Alaska): Sellers retain the full federal-tax-adjusted gain. Texas, Florida, and Tennessee have particularly active veterinary consolidator interest given metro density and population growth.
• Moderate-tax states (Arizona at 2.5 percent, Colorado at 4.4 percent, North Carolina at 4.5 percent): Limited drag on after-tax proceeds, generally not enough to influence transaction timing alone.
• High-tax states (California at 13.3 percent top rate, New York at 10.9 percent, New Jersey at 10.75 percent, Oregon at 9.9 percent, Minnesota at 9.85 percent): Material drag. Owners with mobility may consider domicile change 24+ months before sale; consult tax counsel on residency-establishment requirements.
• Personal goodwill allocation: Across all states, allocating a portion of consideration to personal goodwill (the owner’s individual reputation, client relationships, and clinical skill) can shift up to 40 to 50 percent of proceeds into capital-gains-only treatment, avoiding C-corp double taxation if the practice is C-corp structured. This is one of the highest-impact pre-LOI structural decisions.

This guide does not constitute tax advice; consult your CPA and transaction counsel 18 to 24 months before sale to model the specific structural alternatives available for your practice and state.

Related resources

• Veterinary seller hub, state-by-state data
• Private Equity in Veterinary 2026 (sponsor side)
• How to Sell a Service Business (full playbook)
• Dental practice business valuation (adjacent benchmark)
• Dental DSO PE roll-up tracker (consolidator benchmark)
• Free veterinary business valuation tool